HIV molecular immunology database

 

Patient Detail

Patient Code VID417
Patient Sex
Risk Factor
Infection Country
Infection City
Infection Year
HLA Type A*03:01, A*30:04, B*35:01, B*50:01, C*04:01, C*06:02, DQB1*02, DQB1*05, DRB1*01:01, DRB1*07:01, DRB4
Patient Ethnicity
Progression
Species human
Patient Note Volunteer ID 417 is a healthy HIV-negative subject who was administered the first generation of HIVconsv vaccine, and whose PBMC responded to the peptides annotated above (DDDCM, where D = pSG2.HIVconsv; C = ChAdV63.HIVconsv, 5x1010 virus particles; M = MVA.HIVconsv 2x10 plaque forming units), and whose PBMC responded to the peptides annotated above with a peak EliSpot against CD4+ T cell epitopes of 4260 SFU/106 PBMC. [Borthwick2017CTL, PMID: 28448594 & Borthwick2020HTL, PMID: 31963212].
CTL CD8+ Records 61803, 61806, 61807
T-Helper CD4+ Records 201959, 201960, 201961, 201962, 201963, 201964, 201965, 201966, 201967, 201968, 201969, 201970, 201971, 201972
Antibody Records
Sequence Database Patient ID Record
Questions or comments? Contact us at immuno@lanl.gov
 
Managed by Triad National Security, LLC for the U.S. Department of Energy’s National Nuclear Security Administration
Copyright © 2022 Triad National Security, LLC | Disclaimer/Privacy

Dept of Health & Human Services Los Alamos National Institutes of Health